Augmenting regulatory T cells : new therapeutic strategy for rheumatoid arthritis

Copyright © 2024 Zhang, Liu, Chen, Liu, Zhang, Yin and Xie..

Rheumatoid arthritis (RA) is a chronic, systemic autoimmune condition marked by inflammation of the joints, degradation of the articular cartilage, and bone resorption. Recent studies found the absolute and relative decreases in circulating regulatory T cells (Tregs) in RA patients. Tregs are a unique type of cells exhibiting immunosuppressive functions, known for expressing the Foxp3 gene. They are instrumental in maintaining immunological tolerance and preventing autoimmunity. Increasing the absolute number and/or enhancing the function of Tregs are effective strategies for treating RA. This article reviews the studies on the mechanisms and targeted therapies related to Tregs in RA, with a view to provide better ideas for the treatment of RA.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:15

Enthalten in:

Frontiers in immunology - 15(2024) vom: 01., Seite 1312919

Sprache:

Englisch

Beteiligte Personen:

Zhang, Jiaqian [VerfasserIn]
Liu, Hongjiang [VerfasserIn]
Chen, Yuehong [VerfasserIn]
Liu, Huan [VerfasserIn]
Zhang, Shengxiao [VerfasserIn]
Yin, Geng [VerfasserIn]
Xie, Qibing [VerfasserIn]

Links:

Volltext

Themen:

Foxp3
Journal Article
Regulatory T cells
Research Support, Non-U.S. Gov't
Review
Rheumatoid arthritis
Th17
Therapy

Anmerkungen:

Date Completed 08.02.2024

Date Revised 03.04.2024

published: Electronic-eCollection

Citation Status MEDLINE

doi:

10.3389/fimmu.2024.1312919

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM368114643